C Yea Division

[anonymous]

Eliquis will be promoted until ONE YEAR to the market entry of its generic.
Consideration given to upcoming pricing headwinds.
Unexpectedly generic Pradaxa has eroded market share.
Q2 2025 generic Xarelto is now a factor.
Afib prevalence is not expanding noncaptured is big revenue disappointment.

 

[anonymous]

Eliquis will be promoted until ONE YEAR to the market entry of its generic.
Consideration given to upcoming pricing headwinds.
Unexpectedly generic Pradaxa has eroded market share.
Q2 2025 generic Xarelto is now a factor.
Afib prevalence is not expanding noncaptured is big revenue disappointment.

Is this legit? Not good start to the year

 

[anonymous]

So when is the Eliquis generic expected to be released? What is the end date for CV?